Celularity Inc. Short-Term Debt
Celularity Inc. (CELU) had Short-Term Debt of $42.61 million as of 2024-09-30, per its 10-Q filed 2024-12-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:DebtCurrent · last filed 2024-12-06
- 2024-09-30: Debt, Current $42.61M.
- 2024-07-29: Debt, Current $42.70M.
- 2024-06-30: Debt, Current $41.00M.
- 2024-03-31: Debt, Current $39.80M.
| Period end | Debt, Current |
|---|---|
| 2024-09-30 | $42.61M 10-Q · filed 2024-12-06 |
| 2024-07-29 | $42.70M 10-K · filed 2024-07-30 |
| 2024-06-30 | $41.00M 10-Q · filed 2024-11-07 |
| 2024-03-31 | $39.80M 10-Q · filed 2024-10-16 |
| 2023-12-31 | $39.24M 10-Q · filed 2024-12-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |